Susquehanna International Group
ORTX

Susquehanna International Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Susquehanna International Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-34,028
Closed -$560K – 13829
2023
Q4 		$560K Buy
34,028
+20,583
+153% +$324K ﹤0.01% 8379
2023
Q3 		$104K Buy
+13,445
New +$72.8K ﹤0.01% 10876
2022
Q1 		– Sell
-6,747
Closed -$89K – 14262
2021
Q4 		$89K Sell
6,747
-1,856
-22% -$30.7K ﹤0.01% 12218
2021
Q3 		$198K Buy
8,603
+2,796
+48% +$83.2K ﹤0.01% 11494
2021
Q2 		$255K Sell
5,807
-10,248
-64% -$571K ﹤0.01% 11111
2021
Q1 		$1.17M Sell
16,055
-731
-4% -$51.9K ﹤0.01% 7311
2020
Q4 		$725K Buy
16,786
+14,600
+668% +$654K ﹤0.01% 7460
2020
Q3 		$90K Buy
+2,186
New +$113K ﹤0.01% 9972

Susquehanna International Group's ORTX Position: Q1 2024 in Review

Susquehanna International Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 34,028 shares — an estimated $560K sold.

Susquehanna International Group first reported a position in ORTX in Q3 2020 and held it in 8 quarters. The position peaked at $1.17M in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Susquehanna International Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 34,028 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $560K.
  • Susquehanna International Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 8 quarters.
  • Susquehanna International Group's Orchard Therapeutics plc American Depositary Shares position peaked at $1.17M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.